LIBRA project will be fulfilled from a highly multi-disciplinary consortium comprising expertise and specialization in several fields spanning photonics, surface functionalization, microfluidics, advanced packaging and assembly, artificial intelligence and bioreactor manufacturers. Moreover, LIBRA business strategy includes the market introduction of both the individually developed modules and processes and the overall LIBRA platform through direct exploitation and joint venture creation. LIBRA technologies are expected to provide added value across the value chain of PIC devices, bioreactors, AI and machine learning, laser biofunctionalization and cell therapy bioprocessing. The industrial partners of the consortium are expected to increase their innovation capacity and their product portfolios.